{"transactions":[{"id":1128208,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:15.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":8107,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":8107,"derivative":{"underlying":"Common Stock","underlying_shares":8107},"source":{"system":"sec-edgar","filing":"0001415889-25-015275","document":"form4-06022025_060611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015275/form4-06022025_060611.xml","form_type":"4"}},{"id":1128207,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2025-06-02T22:05:15.000Z","date":"2025-05-29","kind":"grant","planned":false,"acquired":true,"shares":13793,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":13793,"derivative":{"exercise_price":22.29,"expiration_date":"2035-05-28","underlying":"Common Stock","underlying_shares":13793},"source":{"system":"sec-edgar","filing":"0001415889-25-015275","document":"form4-06022025_060611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015275/form4-06022025_060611.xml","form_type":"4"}},{"id":1128206,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2025-06-02T22:05:15.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":false,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2025, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-25-015275","document":"form4-06022025_060611.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015275/form4-06022025_060611.xml","form_type":"4"}},{"id":1128205,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-02T22:05:15.000Z","date":"2025-05-29","kind":"exercise","planned":false,"acquired":true,"shares":9387,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":44041,"source":{"system":"sec-edgar","filing":"0001415889-25-015275","document":"form4-06022025_060611.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588925015275/form4-06022025_060611.xml","form_type":"4"}},{"id":1497016,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:10.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":9387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units will vest in full on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":9387,"derivative":{"underlying":"Common Stock","underlying_shares":9387},"source":{"system":"sec-edgar","filing":"0001415889-24-015085","document":"form4-05312024_060506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015085/form4-05312024_060506.xml","form_type":"4"}},{"id":1497015,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2024-05-31T22:00:10.000Z","date":"2024-05-29","kind":"grant","planned":false,"acquired":true,"shares":15959,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to each stock option will vest quarterly over one year following the date of grant, with the final tranche vesting on the earlier of one year following the date of grant or the next annual meeting of stockholders."}],"balance_after":15959,"derivative":{"exercise_price":14.62,"expiration_date":"2034-05-28","underlying":"Common Stock","underlying_shares":15959},"source":{"system":"sec-edgar","filing":"0001415889-24-015085","document":"form4-05312024_060506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015085/form4-05312024_060506.xml","form_type":"4"}},{"id":1497014,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-05-31T22:00:10.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":false,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vested in full on May 29, 2024, the date on which an annual meeting of stockholders was held."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001415889-24-015085","document":"form4-05312024_060506.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015085/form4-05312024_060506.xml","form_type":"4"}},{"id":1497013,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T22:00:10.000Z","date":"2024-05-29","kind":"exercise","planned":false,"acquired":true,"shares":6652,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":34654,"source":{"system":"sec-edgar","filing":"0001415889-24-015085","document":"form4-05312024_060506.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588924015085/form4-05312024_060506.xml","form_type":"4"}},{"id":1816044,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-08-03T16:40:44.000Z","date":"2023-08-01","kind":"purchase","planned":false,"acquired":true,"shares":15000,"price":1.62,"value":24300.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares (\"ADS\"), each of which currently represents one-half of one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represent the ADS price."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-23-044458","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000120919123044458/doc4.xml","form_type":"4"}},{"id":1867915,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:46:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":6652,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6652,"derivative":{"underlying":"Common Stock","underlying_shares":6652},"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867914,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2023-06-06T01:46:39.000Z","date":"2023-06-01","kind":"grant","planned":false,"acquired":true,"shares":11045,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11045,"derivative":{"exercise_price":23.9,"expiration_date":"2033-05-31","underlying":"Common Stock","underlying_shares":11045},"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867913,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:46:39.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867912,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:46:39.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":false,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867911,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-06-06T01:46:39.000Z","date":"2021-06-22","kind":"exercise","planned":false,"acquired":false,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867910,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:46:39.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":8552,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":28002,"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867909,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:46:39.000Z","date":"2022-06-07","kind":"exercise","planned":false,"acquired":true,"shares":6391,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":19450,"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":1867908,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-06T01:46:39.000Z","date":"2021-06-22","kind":"exercise","planned":false,"acquired":true,"shares":3059,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":13059,"source":{"system":"sec-edgar","filing":"0001209191-23-034699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123034699/doc4.xml","form_type":"4"}},{"id":2211033,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-07-07T17:30:48.000Z","date":"2022-07-06","kind":"grant","acquired":true,"shares":66500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on July 6, 2026, with 25% vesting on July 6, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer."}],"balance_after":66500,"derivative":{"exercise_price":0.4327,"expiration_date":"2032-07-06","underlying":"Common Stock","underlying_shares":66500},"source":{"system":"sec-edgar","filing":"0001415889-22-007543","document":"form4-07072022_020737.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922007543/form4-07072022_020737.xml","form_type":"4"}},{"id":2238134,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-06-10T00:21:40.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":8552,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":8552,"derivative":{"underlying":"Common Stock","underlying_shares":8552},"source":{"system":"sec-edgar","filing":"0001209191-22-035663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035663/doc4.xml","form_type":"4"}},{"id":2238133,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2022-06-10T00:21:40.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":14368,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":14368,"derivative":{"exercise_price":18.27,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":14368},"source":{"system":"sec-edgar","filing":"0001209191-22-035663","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122035663/doc4.xml","form_type":"4"}},{"id":2309822,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-04T17:43:45.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":41500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option will vest and become exercisable in full on January 24, 2026, with 25% vesting on January 24, 2023, and the remainder vesting in twelve equal quarterly installments over the remaining three years, subject to continued service with the Issuer."}],"balance_after":41500,"derivative":{"exercise_price":0.535,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":41500},"source":{"system":"sec-edgar","filing":"0001415889-22-003751","document":"form4-04042022_020426.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922003751/form4-04042022_020426.xml","form_type":"4"}},{"id":2425634,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-26T20:42:27.000Z","date":"2022-01-24","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 24, 2022. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 24, 2023 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":25000,"derivative":{"exercise_price":0.5746,"expiration_date":"2032-01-24","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001415889-22-000792","document":"form4-01262022_050117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588922000792/form4-01262022_050117.xml","form_type":"4"}},{"id":2554085,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2021-10-01T16:56:56.000Z","date":"2021-09-30","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on October 30, 2021, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":10000,"derivative":{"exercise_price":17.45,"expiration_date":"2031-09-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-21-058487","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000120919121058487/doc4.xml","form_type":"4"}},{"id":2636541,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-07-12T16:05:28.000Z","date":"2021-07-08","kind":"grant","acquired":true,"shares":66500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 8, 2021. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 8, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":66500,"derivative":{"exercise_price":1.11,"expiration_date":"2031-07-08","underlying":"Common Stock","underlying_shares":66500},"source":{"system":"sec-edgar","filing":"0001415889-21-003586","document":"form4-07122021_040712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921003586/form4-07122021_040712.xml","form_type":"4"}},{"id":2656314,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-06-24T20:42:41.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":6391,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":6391,"derivative":{"underlying":"Common Stock","underlying_shares":6391},"source":{"system":"sec-edgar","filing":"0001209191-21-043043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043043/doc4.xml","form_type":"4"}},{"id":2656313,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2021-06-24T20:42:41.000Z","date":"2021-06-22","kind":"grant","acquired":true,"shares":11637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":11637,"derivative":{"exercise_price":24.88,"expiration_date":"2031-06-21","underlying":"Common Stock","underlying_shares":11637},"source":{"system":"sec-edgar","filing":"0001209191-21-043043","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121043043/doc4.xml","form_type":"4"}},{"id":2662248,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2021-06-21T16:10:31.000Z","date":"2021-06-18","kind":"purchase","acquired":true,"shares":50000,"price":1.19,"value":59500.0,"ownership":{"direct":true},"balance_after":78843,"source":{"system":"sec-edgar","filing":"0001415889-21-003112","document":"form4-06212021_040601.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921003112/form4-06212021_040601.xml","form_type":"4"}},{"id":2671515,"issuer":{"id":5096,"kind":"organization","name":"DBV Technologies S.A."},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrant (right to buy)","published_at":"2021-06-11T16:58:00.000Z","date":"2021-06-10","kind":"purchase","acquired":true,"shares":6837,"price":7.12,"value":48679.44,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"This price is in US Dollars and reflects the conversion of EUR to USD at an exchange rate of $1.2176 to EUR 1.00 as of June 10, 2021."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This price is in US Dollars and reflects the conversion of EUR to USD at an exchange rate of $1.2176 to EUR 1.00 as of June 10, 2021."}],"balance_after":6837,"derivative":{"exercise_price":13.09,"exercise_date":"2021-06-10","expiration_date":"2025-06-10","underlying":"Ordinary Shares","underlying_shares":6837},"source":{"system":"sec-edgar","filing":"0001209191-21-039890","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000120919121039890/doc4.xml","form_type":"4"}},{"id":2807380,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2021-03-05T17:55:20.000Z","date":"2021-03-05","kind":"purchase","acquired":true,"shares":10000,"price":3.895,"value":38950.0,"ownership":{"direct":true},"balance_after":28843,"source":{"system":"sec-edgar","filing":"0001415889-21-001353","document":"form4-03052021_020310.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000141588921001353/form4-03052021_020310.xml","form_type":"4"}},{"id":2923505,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-05T16:43:16.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 4, 2021. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 4, 2022 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":200000,"derivative":{"exercise_price":4.02,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001179110-21-000155","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911021000155/edgar.xml","form_type":"4"}},{"id":3015678,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-10-02T20:38:24.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 1, 2020, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":12.88,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-053397","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000120919120053397/doc4.xml","form_type":"4"}},{"id":3015677,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (right to buy)","published_at":"2020-10-02T20:37:51.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":7000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 12 month period: 1/12th on November 1, 2020, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date."}],"balance_after":7000,"derivative":{"exercise_price":12.88,"expiration_date":"2030-09-30","underlying":"Common Stock","underlying_shares":7000},"source":{"system":"sec-edgar","filing":"0001209191-20-053396","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000120919120053396/doc4.xml","form_type":"4"}},{"id":3100129,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-06-25T22:00:15.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":3059,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in full upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":3059,"derivative":{"underlying":"Common Stock","underlying_shares":3059},"source":{"system":"sec-edgar","filing":"0001209191-20-038979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038979/doc4.xml","form_type":"4"}},{"id":3100128,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Options (Right to Buy)","published_at":"2020-06-25T22:00:15.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":5579,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest quarterly over one year following the date of grant, with the final tranche vesting upon the earlier of one year following the date of grant or the next annual meeting date."}],"balance_after":5579,"derivative":{"exercise_price":52.73,"expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":5579},"source":{"system":"sec-edgar","filing":"0001209191-20-038979","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120038979/doc4.xml","form_type":"4"}},{"id":3404253,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-30T17:23:20.000Z","date":"2019-09-27","kind":"purchase","acquired":true,"shares":7962,"price":11.8686,"value":94497.7932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported price in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.85 to $11.90 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001567619-19-018888","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000156761919018888/doc1.xml","form_type":"4"}},{"id":3404252,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-09-30T17:23:20.000Z","date":"2019-09-26","kind":"purchase","acquired":true,"shares":2038,"price":11.9,"value":24252.2,"ownership":{"direct":true},"balance_after":2038,"source":{"system":"sec-edgar","filing":"0001567619-19-018888","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000156761919018888/doc1.xml","form_type":"4"}},{"id":3476278,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-28T21:14:03.000Z","date":"2019-06-26","kind":"grant","acquired":false,"shares":22500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":22500,"derivative":{"exercise_price":25.24,"expiration_date":"2029-06-26","underlying":"Common Stock","underlying_shares":22500},"source":{"system":"sec-edgar","filing":"0001209191-19-039525","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119039525/doc4.xml","form_type":"4"}},{"id":3550984,"issuer":{"id":39180,"kind":"organization","name":"KalVista Pharmaceuticals, Inc.","symbol":"KALV"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Director Stock Option (Right to Buy)","published_at":"2019-04-23T17:29:04.000Z","date":"2019-04-22","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests over a 3 year period: 1/36th vests on May 22, 2019, after which 1/36th of the total shares vest monthly, subject to reporting person's continued service through each vesting date."}],"balance_after":14000,"derivative":{"exercise_price":26.4,"expiration_date":"2029-04-21","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001567619-19-009059","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1318485/000156761919009059/doc1.xml","form_type":"4"}},{"id":3900451,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:07:40.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Annual committee grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":17.52,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-18-000913","document":"form4-06082018_020624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000913/form4-06082018_020624.xml","form_type":"4"}},{"id":3900450,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-08T21:07:40.000Z","date":"2018-06-06","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":17.52,"expiration_date":"2028-06-05","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-18-000913","document":"form4-06082018_020624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000913/form4-06082018_020624.xml","form_type":"4"}},{"id":4021215,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T23:09:06.000Z","date":"2018-03-02","kind":"purchase","acquired":true,"shares":3000,"price":22.52,"value":67560.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001415889-18-000338","document":"form4-03022018_030351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000338/form4-03022018_030351.xml","form_type":"4"}},{"id":4021214,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T23:09:06.000Z","date":"2018-03-01","kind":"purchase","acquired":true,"shares":2000,"price":24.52,"value":49040.0,"ownership":{"direct":true},"balance_after":7000,"source":{"system":"sec-edgar","filing":"0001415889-18-000338","document":"form4-03022018_030351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000338/form4-03022018_030351.xml","form_type":"4"}},{"id":4021213,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T23:09:06.000Z","date":"2018-03-01","kind":"purchase","acquired":true,"shares":3000,"price":24.09,"value":72270.0,"ownership":{"direct":true},"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001415889-18-000338","document":"form4-03022018_030351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000338/form4-03022018_030351.xml","form_type":"4"}},{"id":4021212,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-03-02T23:09:06.000Z","date":"2018-03-01","kind":"purchase","acquired":true,"shares":2000,"price":23.02,"value":46040.0,"ownership":{"direct":true},"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001415889-18-000338","document":"form4-03022018_030351.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918000338/form4-03022018_030351.xml","form_type":"4"}},{"id":4254780,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-07-19T21:25:49.000Z","date":"2017-07-17","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option vest and become exercisable at the end of each 3-month period following the date of ACADIA's 2017 Annual Meeting of Stockholders, or June 13, 2017."}],"balance_after":15000,"derivative":{"exercise_price":28.85,"expiration_date":"2027-07-16","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-17-001230","document":"form4-07192017_020738.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917001230/form4-07192017_020738.xml","form_type":"4"}},{"id":4282551,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":79032,"kind":"person","name":"SOLAND DANIEL B","position":1,"cik":"0001318485","reported_name":"SOLAND DANIEL B","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-14T22:16:20.000Z","date":"2017-06-13","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable at the end of each 3-month period following the date of grant."}],"balance_after":15000,"derivative":{"exercise_price":27.25,"expiration_date":"2027-06-12","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001415889-17-000993","document":"form4-06142017_030610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588917000993/form4-06142017_030610.xml","form_type":"4"}}]}